Amazon.com (AMZN) appears one step closer to infiltrating another industry.

Throughout the past year, the e-commerce giant has been gaining approval to become a wholesale distributor from several pharmaceutical boards, the St. Louis Post-Dispatch reported.

Amazon has attained authorization for wholesale pharmacy licenses in at least 12 states, including Nevada, Arizona, North Dakota, Louisiana, Alabama, New Jersey, Michigan, Connecticut, Idaho, New Hampshire, Oregon, and Tennessee, the report said. An additional application is pending in Maine.

It remains unclear whether the filings validate Amazon's plan to infiltrate the prescription drug delivery business, the paper noted. 

The report has helped to drag down the shares of pharmacy stocks including CVS (CVS) , lower over 4%, Walgreens Boots Alliance (WBA) , down over 2.8%, and Rite Aid (RAD) , sinking over 7%.

Shares of Express Scripts (ESRX) , a pharmacy benefit managers (PBMs), a third-party administrator of prescription drug programs for commercial health plans and self-insured employer plans, were sinking over 3%.

More of What's Trending on TheStreet:

More from Stocks

Tesla's People Problem and the Inscrutable Musk: 2 Things That Make You Go Hmmm

Tesla's People Problem and the Inscrutable Musk: 2 Things That Make You Go Hmmm

Dow Hits Another Closing High to End Record Setting Week

Dow Hits Another Closing High to End Record Setting Week

Citigroup Has Finally Broken Out of a Six-Month Base Pattern

Citigroup Has Finally Broken Out of a Six-Month Base Pattern

Jumping Juniper Networks: JNPR Near Major Upside Breakout Amid Quant Upgrade

Jumping Juniper Networks: JNPR Near Major Upside Breakout Amid Quant Upgrade

Micron's Slide Could Create a Great Buying Opportunity

Micron's Slide Could Create a Great Buying Opportunity